Source: Pharmabiz

Orbit Discovery Ltd: Orbit Discovery and Evergreen Theragnostics expand research collaboration to advance targeted therapeutics development

Orbit Discovery, a leading provider of peptide discovery services, and Evergreen Theragnostics, a radiopharmaceutical company at the forefront of precision medicine, today announced an extension to their research collaboration to find novel targeting peptides for radiopharmaceutical delivery.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Neil Butt's photo - CEO of Orbit Discovery Ltd

CEO

Neil Butt

CEO Approval Rating

90/100

Read more